BioBeat17: Re-shaping biotech partnering

16 November 2017 13:30-18:30, London, United Kingdom


Introduction
The Francis Crick Institute is delighted to host this half-day summit for scientists, investors and entrepreneurs on steeping up biotech partnering to make greater impact on health and wealth.  

13.30-14.00 Registration


14.00 - 14.10 Welcome
Veronique Birault, Head of Translation, The Francis Crick Institute
Miranda Weston-Smith, Founder, BioBeat

14.10 - 14.35 Partnering Case Study at the Crick
Chair: Tamsin Sayer, Head of Collaboration, The Francis Crick Institute
Lucy Collinson, Head of Electron Microscopy, The Francis Crick Institute

14.40 - 15.30 Catalysing biotech partnering opportunities
Chair: Veronique Birault, Head of Translation, The Francis Crick Institute
On the panel: Lucinda Crabtree, Senior Investment Analyst, Woodford Patient Capital, Jane Dancer, CBO, F-Star Biotechnology, Sarah Howell, CEO, Arecor, Natalie Mount, CSO, GammaDelta Therapeutics

15.30 - 16.00 Tea and coffee

16.00 -17.00 Partnering and careers permeability
Chair: Kate Bingham, Managing Partner, SV Life Sciences
On the panel: Barbara Domayne-Hayman, CBO, Autifony and Chair, Puridify, Julie Simmonds, Director, Equity Research, Panmure Gordon, Carmel Reilly, CEO, NeuroCentrx Pharma, Andrea Spezzi, CMO and Co-founder, Orchard Therapeutics, Angela Russell, Associate Professor Medicinal Chemistry, University of Oxford and Co-founder, OxStem

17.00 -18.30 Drinks and networking
 
Speakers
  • Veronique Birault, Head of Translation The Francis Crick Institute, United Kingdom
  • Miranda Weston-Smith, Founder BioBeat, United Kingdom
  • Tamsin Sayer, Head of Collaboration The Francis Crick Institute, United Kingdom
  • Lucy Collinson, Head of Electron Microscopy The Francis Crick Institute, United Kingdom
  • Lucinda Crabtree, Senior Investment Analyst Woodford Patient Capital, United Kingdom
  • Jane Dancer, Chief Business Officer F-Star Biotechnology, United Kingdom
  • Sarah Howell, Chief Executive Officer Arecor, United Kingdom
  • Natalie Mount, Chief Scientific Officer GammaDelta Therapeutics, United Kingdom
  • Kate Bingham, Managing Partner SV Life Sciences, United Kingdom
  • Barbara Domayne-Hayman, Chief Business Officer and Chair CBO, Autifony, Chair, Puridify, United Kingdom
  • Julie Simmonds, Director, Equity Research Panmure Gordon, United Kingdom
  • Carmel Reilly, Chief Executive Officer NeuroCentrx Pharma, United Kingdom
  • Andrea Spezzi, Chief Medical Officer Orchard Therapeutics, United Kingdom
  • Angela Russell, Associate Professor Medicinal Chemistry, and Co-founder University of Oxford and OxStem, United Kingdom

Sponsorship & supporting organisations
Venue
The Francis Crick Institute

The Francis Crick Institute, 1 Midland Rd, Kings Cross, London, NW1 1AT, United Kingdom

Organised by
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement Spotlight Advertisement

E-mail Enquiry
*
*
*
*